Hot Pursuit     26-Sep-11
Orchid Chemicals slips as fire erupts at Chennai R&D unit
Orchid Chemicals & Pharmaceuticals fell 3.54% at Rs 175.55 at 13:37 IST on BSE after the company said that a fire broke out at a portion of the new drug discovery laboratory of its research subsidiary--Orchid Research Laboratories--in Chennai.

The announcement was made during trading hours today, 26 September 2011.

Meanwhile, the BSE Sensex was down 111.54 points, or 0.69%, to 16,050.52.

On BSE, 4.52 lakh shares were traded in the counter as against an average daily volume of 5.33 lakh shares in the past one quarter.

The stock hit a high of Rs 184.30 and a low of Rs 170.25 so far during the day. The stock had hit a 52-week low of Rs 165 on 9 August 2011. The stock had hit a 52-week high of Rs 344.40 on 26 October 2010.

The stock had underperformed the market over the past one month until 23 September 2011, falling 8.34% compared with the Sensex's 2.04% decline. The scrip had also underperformed the market in past one quarter, sliding 28.11% as against 8.83% decline in the Sensex.

The mid-cap pharmaceutical company has an equity capital of Rs 70.44 crore. Face value per share is Rs 10.

Orchid Chemicals & Pharmaceuticals said the fire erupted at a portion of the new drug discovery laboratory, located at the company's research subsidiary Orchid Research Laboratories at Sholinganallur in Chennai. The fire was brought under control by the Tamil Nadu Fire Services squad. The fire damaged office, laboratory equipment, furniture and building interiors. However, there were no human casualties, the company added.

Orchid Chemicals & Pharmaceuticals' net profit fell 28.1% to Rs 15.54 crore on 23.1% increase in net sales to Rs 373.76 crore in Q1 June 2011 over Q1 June 2010.

Orchid Chemicals & Pharmaceuticals is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. The firm enjoys a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system, cardio vascular segment, nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients, finished dosage forms, new drug discovery, novel drug delivery systems and contract research and manufacturing services.

Previous News
  Orchid Pharma reports consolidated net loss of Rs 5.39 crore in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:28 )
  Broader mkt underperforms; metal stocks lose shine
 ( Market Commentary - Mid-Session 23-Jun-23   11:35 )
  Orchid Pharma reports standalone net loss of Rs 63.74 crore in the March 2016 quarter
 ( Results - Announcements 28-May-16   11:03 )
  Orchid Pharma reports consolidated net profit of Rs 7.59 crore in the December 2022 quarter
 ( Results - Announcements 10-Feb-23   07:38 )
  Orchid Pharma launches QIP issue
 ( Corporate News - 23-Jun-23   10:12 )
  Orchid Pharma to conduct board meeting
 ( Corporate News - 29-Nov-22   10:06 )
  Orchid Pharma reports standalone net loss of Rs 60.98 crore in the December 2016 quarter
 ( Results - Announcements 07-Feb-17   17:06 )
  Orchid Pharma hits the roof on launching QIP issue
 ( Hot Pursuit - 23-Jun-23   11:26 )
  Orchid Pharma jumps after receiving USFDA nod for Exblifep injections
 ( Hot Pursuit - 23-Feb-24   16:18 )
  Orchid Pharma reports consolidated net loss of Rs 15.01 crore in the June 2022 quarter
 ( Results - Announcements 11-Aug-22   08:49 )
  Orchid Pharma reports consolidated net loss of Rs 22.66 crore in the June 2020 quarter
 ( Results - Announcements 08-Sep-20   10:36 )
Other Stories
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
Back Top